Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Answering the Questions on Considering an ART Switch During Pregnancy

Source: Strategies for Optimal HIV Treatment and Prevention
Hear from expert faculty as they answer questions and discuss key considerations when determining whether and how to switch antiretroviral therapy in pregnant people with HIV.
person default
Annette Haberl, MD
William R. Short, MD, MPH, AAHIVS
Released: December 19, 2022

In this episode, Annette Haberl, MD, and William R. Short, MD, MPH, AAHIVS, discuss when to consider an ART switch during pregnancy, including:

  • Current DHHS, EACS, WHO, BHIVA, and German/Austrian guidelines for the use of ARVs in pregnancy
  • What data and recommendations for the use of ARVs during pregnancy are currently missing from the guidelines
  • Available data on newer ARVs in the ARV pregnancy registry
  • Pharmacokinetic data for newer ARVs including BIC/FTC/TAF and LA CAB + RPV in pregnancy
  • Recommendations for 2-drug ART regimens in pregnancy
  • What to do when someone becomes pregnant on a newer ART regimen that is not yet recommended by the guidelines

Information on this Educational Activity

Faculty

Annette Haberl, MD

Physician
Head of HIV and Women, HIVCENTER Frankfurt
Department of Infectious Diseases
Hospital of the Johann Wolfgang Goethe-University
Frankfurt, Germany

Annette Haberl, MD: consultant/advisor/speaker: Gilead, Janssen Cilag, Merck Sharpe & Dohme, ViiV.
William R. Short, MD, MPH, AAHIVS

Associate Professor of Medicine
Division of Infectious Diseases
Department of Medicine
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania

William R. Short, MD, MPH, AAHIVS: non-CME/CE services: Janssen; consultant/advisor/speaker: ViiV.

Program Medium

This program has been made available online.

Acknowledgements

Provided by Clinical Care Options, LLC
Contact Info

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Gilead Sciences, Inc.
ViiV Healthcare

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings